ClinicalTrials.Veeva

Menu

Effects of Cord Blood 25-hydroxy-vitamin D Level on Early Neonatal Morbidities

Z

Zekai Tahir Burak Women's Health Research and Education Hospital

Status

Completed

Conditions

Neonatal Hypocalcemia
Neonatal Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT02147327
sevit25D3

Details and patient eligibility

About

Cholecalciferol (vitamin D3) is a prohormone and its active form is 1,25 dihydroxycholecalciferol. This hormone has effect on both calcium, phosphorus and bone metabolism and also bone morrow, muscle, heart and immune system. For a long time, maternal low vitamin D level is a well known problem for our country and the level was reported as <10 ng/ml for 46-80% of mothers.The most prominent risk factor was determined as low socioeconomic status. Therefore, the level of 25-hydroxy-vitamin D is supposed to be in relation with several neonatal morbidities and maternal complications of pregnancy.

Enrollment

120 patients

Sex

All

Ages

Under 30 minutes old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Term or preterm newborns which are hospitalized in the Neonatal Intensive Care Unit of our hospital

Exclusion criteria

  • Preterm babies born before the 24. gestational week
  • Babies with complex cardiac anomalies and/or dysmorphic features

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems